SOLICITATION NOTICE
U -- follow-on Molecular Diagnostics and Cytogenetics Rare Disorders Fellows Training
- Notice Date
- 12/16/2013
- Notice Type
- Presolicitation
- NAICS
- 611430
— Professional and Management Development Training
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- HHS-NIH-NHLBI-CSB-(HG)-2014-037-DLM
- Archive Date
- 1/3/2014
- Point of Contact
- Dorothy Maxwell, Phone: 301-435-0352
- E-Mail Address
-
maxwelld@mail.nih.gov
(maxwelld@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Heart, Lung, and Blood Institute (NHLBI) Office of Acquisition (OA) on behalf of the National Human Genome Research Institute (NHGRI), intends to negotiate and award a purchase order on a noncompetitive sole source basis to Gene DX, 207 Perry Parkway, Gaithersburg, Maryland 20877 for a follow-on Molecular Diagnostics and Cytogenetics Rare Disorders Fellows Training for NHGRI. Procurement: This is a Follow-On Requirement. Background: The National Institutes of Health (NIH) is the nation's leading medical research agency and the primary Federal agency conducting and supporting medical discoveries that improve people's health and save lives. The National Human Genome Research Institute (NHGRI), mission continues to be the study of the ethical, legal and social implications (ELSI) of genome research. NHGRI also supports the training of investigators and the dissemination of genome information to the public and to health professionals. Division of Intramural Research (DIR) was established to serve as a hub where development of technology for the rapid isolation and analysis of disease genes will be carried out. The DIR's basic research laboratories and clinical branches develop and use the most advanced techniques to conduct research in medical genetics. Research includes identifying and understanding the molecular basis of human genetic disease and planning and carrying out clinical trials to test methods for the treatment. The mission of the DIR includes the training of physicians and doctoral degree fellows in genetics and genomics through the Medical Genetics and Genomic Medicine Residency and Fellowship Training Programs. These programs are administered by the Office of the Clinical Director (OCD) and are accredited by the American Board of Medical Genetics (ABMG).Requirements for board certification of competency of our trainees includes laboratory experiences in cytogenetics and molecular genetics, including genomics. To meet these requirements the Medical Genetics Branch and OCD seek nearby institutions to provide these components of training for board certification in Clinical Genetics, Clinical Molecular Genetics, Clinical Biochemical Genetics and Clinical Cytogenetics. The laboratory experience of the trainees must include a wide array of molecular diagnostic testing in the fields of neurodegenerative disorders, late onset disorders, imprinting disorders, mental retardation, neuromuscular disorders, and metabolic diseases, including prenatal diagnosis. In addition, the training in cytogenetics must include conventional karyotyping as well as FISH and microarrays in both pre- and post-natal settings. The laboratory aspect of the training program will need to be conducted in diagnostic laboratories with equipment and personnel to provide the hands-on experience required for board certification by ABMB. The staff, which must include ABMG board certified laboratory directors, will be required to train fellows in applicable laboratory techniques and the clinical interpretation and implications of the test results. The staff must also participate in the comprehensive teaching of fellows; including participation in lecture series, journal clubs, and case conferences. The cost of disposable supplies used by trainees will be included in the contract. Period of Performance : Base: January 1, 2014 through December 31, 2014 Option 1: January 1, 2015 through December 31, 2015 Option 2: January 1, 2016 through December 31, 2016 Justification: This project is necessary for NHGRI/DIR because it will help provide the DIR with access to CLIA/CAO and ABMG approved settings to train fellows in the laboratory techniques of cytogenetic and molecular genetics for the diagnosis of genetic disorders and the genetic implications of these test results. There are no grants or in-house ongoing efforts planned that are directly related to this project. The purpose of this contract is to continue to maintain formal training program sites for the instruction of medical and doctoral fellows as part of the requirements for board certification in Clinical Genetics, Clinical Cytogenetics, Clinical Biochemical Genetics and Clinical Molecular Genetics. The goals of the program are to: 1. Provide a training facility that will conduct two week training experiences in cytogenetics genetics for each of our Medical Genetics trainees seeking certification in Clinical Molecular Genetics and Clinical Biochemical Genetics as well as our Clinical Genetic trainees. 2. Provide a training facility that will conduct one month training experiences in cytogenetics genetics for each of our Medical Genetics trainees seeking certification in Clinical Cytogenetics. 3. Provide a training facility that will conduct one-month training experiences in molecular genetic testing for rare genetic conditions for each of our Medical Genetics trainees seeking certification in Clinical Molecular Genetics, Clinical Cytogenetics and Clinical Biochemical Genetics as well as our Clinical Genetic trainees. 4. Provide a training facility that will conduct two week training experiences in medical genomics for each of our Medical Genetics trainees seeking certification in Clinical Molecular Genetics, Clinical Cytogenetics and Clinical Biochemical Genetics as well as our Clinical Genetic trainees.\ 5. To provide a genetic counselor to assist in the training of the fellows in the genetic counseling implications of the diagnoses that have been made. 6. To participate in the comprehensive training of all trainees in genetics as part of the Medical Genetics and Genomic Medicine Residency and Fellowship Programs. Contractor Requirements: Specific tasks to be performed are: 1. Each year the training program will enroll up to four (4) clinical genetics fellows, (2) clinical biochemical genetics fellows, and (4) clinical molecular genetics fellows. Each fellow will spend one (1) month each in the molecular genetics laboratory, two (2) weeks in the cytogenetics laboratory, and two (2) weeks in the genomics rotation. Each year the training program will enroll up to one (1) clinical cytogenetic fellow who will spend one (1) month each in the cytogenetic and molecular genetic laboratories, and two (2) weeks in the genomics rotation. 2. Track the progress of each fellow to insure that they will have had necessary experiences for AMGB certification. 3. The Contractor shall describe procedures needed to successfully train the fellows in required laboratory techniques and the genetic implications of the molecular diagnostic tests. REGULATORY AUTHORITY: This acquisition is conducted under the authority of 41 U.S.C. 253(c) as set forth in FAR Part 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements. ADDITIONAL INFORMATION: Industry Classification (NAICS) Code is 611430, Professional and Management Development Training, small business size standard in millions: $10.0M.The acquisition is being conducted under FAR Part 13, simplified acquisition procedures, therefore the requirements of FAR Part 6 B Competitive Requirements are not applicable (FAR Part 6.001). The resultant Contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-71, November 25, 2013. This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by December 19, 2013 and must reference synopsis number HHS-NIH-NHLBI-CSB-(HG)-2014-037-DLM, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6149, Bethesda, Maryland 20892-7902, Attention: Dorothy Maxwell. Response may be submitted electronically to maxwelld@mail.nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/HHS-NIH-NHLBI-CSB-(HG)-2014-037-DLM/listing.html)
- Place of Performance
- Address: NIH and Vendor's Training Location in Gaithersburg, Maryland, United States
- Record
- SN03252970-W 20131218/131216235730-dd07b237ba1243b5764b57dc64454768 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |